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Introduction 
Human mesenchymal stem cells (hMSCs) isolated from various adult tissues are primary candidates in cell 
therapy and tissue regeneration.  The pro-regenerative properties of hMSCs are largely attributed to their trophic 
effects by the release of factors that coordinately modulate the progression of inflammation and enhance the 
endogenous tissue repair by host progenitor cells.  However, immediately after isolation and upon culture 
expansion, hMSCs acquire and accumulate genetic and phenotypic changes that significantly alter their 
phenotypic properties with reduced clonogenic and therapeutic potential.  The culture-induced changes are not 
only correlated with reduced clonogenicity and proliferation but also with reduced therapeutic outcome in various 
disease models.  Thus, preserving hMSC therapeutic potency following in vitro expansion is an important goal in 
hMSC application.  Once viewed as a mere consequence of the state of a cell, metabolism is now known to play 
active roles in regulating cellular events that govern stem cell phenotype and functional properties.  Our long term 
objective is to understand the role of energy metabolism in regulating hMSC cell fate with ultimate goals of 
developing metabolic strategies to augment hMSCs therapeutic properties. 
 
Results 
Our recent studies show that hMSCs have heterogeneity at the level of primary energy metabolism [1] and 
possess metabolic plasticity to reconfigure their metabolic network in their reacquisition of stem cell primitive 
properties and immune-modulatory property [2].  First, 13C-glucose-based metabolomics analysis suggested that 
hMSC are metabolically heterogeneous and that clonogenic subpopulation of hMSCs enriched in low density 
culture (100 cells/cm2) possesses a metabolic phenotype that differs from that of hMSCs in high-density (3,000 
cells/cm2) in their levels of glycolysis metabolism and pentose phosphate pathway (PPP).  Metabolic inhibition 
studies revealed that glycolysis and PPP play active roles in maintaining hMSCs clonogenicity by regulating ATP 
generation, maintaining cellular redox state, and scavenging exogenous reactive oxygen species [1].  Second, we 
showed that hMSCs possess metabolic plasticity and effectively reconfigure their metabolism during 3D 
aggregation culture, and that this metabolic reconfiguration plays a central role in their reacquisition of primitive 
phenotypic properties [2].  Specifically, aggregate formation of hMSCs remodeled their mitochondrial network with 
reduced mitochondrial membrane potential, resulting in metabolic reconfiguration with reduced mitochondrial citric 
acid cycle (TCA cycle) activity, increased aerobic glycolysis, and anaplerotic flux.  The effects of metabolic 
reconfiguration on stem cell gene expression and secretory function was recapitulated in the gain- and loss-of-
function experiments using small molecule metabolic modulators, confirming its functional role in regulating hMSC 
properties.  Finally, we showed that hMSC immuno-activation in response to interferon-γ (IFN-γ) treatment is 
associated with metabolic reconfiguration towards increased aerobic glycolysis, characterized by increased 
glucose consumption and upregulation of glycolysis-related genes and enzymes.  We further demonstrated that 
both glucose deprivation and glycolysis inhibition were sufficient to abolish the secretion of indoleamine 2,3-
dioxygenase (IDO) a critical anti-inflammatory cytokine secreted by hMSCs, suggesting the central role of aerobic 
glycolysis in regulating hMSC immunomodulatory properties. 
 
Conclusions 
Together, the results revealed the mechanistic connection between metabolic regulation and hMSC therapeutic 
phenotype, and demonstrated the regulation of metabolism as a strategy in potentiating hMSCs properties for cell 
therapy.  In the presentation, the implication of these findings in hMSC bioprocessing and therapeutic application 
will be discussed.  
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